| Phase 1 | Phase 2 | ||
---|---|---|---|---|
Subscale | Total (n = 30) | Male (n = 20) | Female (n = 10) | Total (n = 18) |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
Positive impact | 71.47 (24.32) | 73.85 (26.15) | 66.70 (20.58) | 66.56 (21.62) |
Negative impact | 62.97 (21.26) | 64.00 (21.03) | 62.45 (21.91) | 60.17 (20.43) |
Positive support | 18.53 (3.78) | 17.10 (3.61)** | 21.40 (2.17)** | 16.28 (3.88) |
Negative support | 9.37 (3.07) | 9.80 (3.38) | 8.50 (2.22) | 7.67 (2.97) |
Positive dimensions | 4.73 (2.32) | 4.95 (2.37) | 4.30 (2.26) | 4.33 (1.64) |
Negative dimensions | 9.40 (3.59) | 9.75 (3.71) | 8.70 (3.40) | 9.78 (3.25) |
Subscale | Schizophrenia | Brief Psychotic | Bipolar I | Schizoaffective |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
Positive impact | 73.07 (24.90) | 67.00 (15.56) | 71.45 (24.32) | 64.00 (14.14) |
Negative impact | 60.20 (22.27) | 73.50 (10.61) | 65.18 (23.37) | 61.00 (14.14) |
Positive support | 16.93 (4.16) | 23.00 (1.41) | 19.27 (2.28) | 22.00 (2.83) |
Negative support | 9.40 (3.20) | 10.50 (2.12) | 8.91 (2.77) | 10.50 (6.36) |
Positive dimensions | 4.93 (2.37) | 4.00 (2.83) | 4.82 (2.44) | 3.50 (2.12) |
Negative dimensions | 8.67 (3.39) | 8.00 (4.24) | 11.00 (3.66) | 7.50 (3.54) |